A novel drug PNU-120596 (PNU), a positive allosteric modulator (PAM) of the alpha7 nicotinic acetylcholine receptor (α7-nAChR), has demonstrated promising results in reducing infarct volumes and improving motor function, primarily in a rat stroke model (Gaidhani and Uteshev, 2018). The gene discussed is CHRNA7; the disease is stroke disorder.